You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: November 29, 2023

Exela Pharma Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for EXELA PHARMA, and what generic alternatives to EXELA PHARMA drugs are available?

EXELA PHARMA has twenty-two approved drugs.

There are fifteen US patents protecting EXELA PHARMA drugs.

Summary for Exela Pharma

US Patents:	15
Tradenames:	20
Ingredients:	20
NDAs:	22
Patent Litigation for Exela Pharma:	See patent lawsuits for Exela Pharma

Drugs and US Patents for Exela Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Exela Pharma	VAZCULEP	phenylephrine hydrochloride	SOLUTION;INTRAVENOUS	204300-003	Jun 27, 2014	AP1	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Exela Pharma	AKOVAZ	ephedrine sulfate	SOLUTION;INTRAVENOUS	208289-001	Apr 29, 2016	AP	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Exela Pharma	DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%	diltiazem hydrochloride	SOLUTION;INTRAVENOUS	215252-001	Oct 28, 2021		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Exela Pharma	CAFFEINE CITRATE	caffeine citrate	SOLUTION;ORAL	077304-001	Sep 21, 2006	AA	RX	No	Yes		⤷ Try a Trial				⤷ Try a Trial
Exela Pharma	NIPRIDE RTU IN SODIUM CHLORIDE 0.9%	sodium nitroprusside	SOLUTION;INTRAVENOUS	209387-002	Dec 7, 2017		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Moodys

McKinsey

Express Scripts

Johnson and Johnson

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.